Search - tctmd.com

Displaying 81 - 100 of 141

Sort: Relevancy | Date

News Daily News

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

Todd Neale

January 30, 2019

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Yael L. Maxwell

October 19, 2018

Presentation TCT 2018

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Wojtek Wojakowski, Mirvat Alasnag, Ori Ben-Yehuda, Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Mohamed Ahmed Sobhy, Pedro de Araujo Goncalves

September 23, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Daily News

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Yael L. Maxwell

September 18, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Shelley Wood

July 23, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Industry News

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

June 28, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

L.A. McKeown

May 11, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

News Daily News

Proposed Medicare Cuts May Hit TAVR Especially Hard

Caitlin E. Cox

March 21, 2018

News Featured Fellow

Matthew Czarny, MD

Yael L. Maxwell

February 13, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

L.A. McKeown

January 04, 2018

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

Advertisement

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

Better TAVR Outcomes With More Experienced Operators: New York Database

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Proposed Medicare Cuts May Hit TAVR Especially Hard

Matthew Czarny, MD

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content